| Description : Vaximune 23 is a vaccine designed to protect against infections caused by Streptococcus pneumoniae bacteria. It contains components from 23 different strains of the bacteria to provide broad-spectrum coverage. Uses : The primary use of Vaximune 23 is the prevention of pneumococcal disease, including pneumonia, meningitis, and bacteremia (bloodstream infection), particularly in adults over 50 years of age and individuals with certain medical conditions that increase their risk of pneumococcal infection. Interactions : Vaximune 23 generally has few interactions with other medications. However, individuals should inform their healthcare providers about all medications and vaccines they are taking, as well as any medical conditions they have, to ensure the safety and efficacy of vaccination. Therapeutic Effects : Vaximune 23 works by stimulating the body's immune system to produce antibodies against Streptococcus pneumoniae bacteria. These antibodies help the immune system recognize and destroy the bacteria if exposure occurs, preventing pneumococcal infections and their potentially serious complications. It's important to note that while Vaximune 23 provides protection against pneumococcal disease, it does not protect against all causes of pneumonia or other respiratory infections. Therefore, individuals should continue to practice good hygiene and seek medical care if they develop symptoms of respiratory illness. |
No content available
